about
Outcomes and predictors of harmful relapse following liver transplantation for alcoholic liver disease in an Australian population.Hepatitis B screening before rituximab therapy: a multicentre South Australian study of adherence.A Chronic Disease Management Model for Cirrhosis is Cost-Effective: Analysis of a Randomized Controlled Trial.Early palliative care referral in patients with end stage liver disease is associated with reduced resource utilisationVery early-onset of Cryptococcus neoformans disease following liver transplantation: Report of two cases and a review of the literatureHigh rates of indeterminate interferon-gamma release assays for the diagnosis of latent tuberculosis infection in liver transplantation candidatesStereotactic body radiation therapy for early hepatocellular carcinoma: a retrospective analysis of the South Australian experience
P50
Q39189328-07048E48-F5C7-48CA-B107-6937B26C4D3CQ47551989-057B02B7-747D-47D8-BA08-221DA83A6E59Q49806053-F2CE792E-2596-42E1-9342-05B3B8D096B8Q90714433-7C3A28A7-1CF8-4ACE-BEC3-948159DC9A25Q91564024-E2855558-E9F7-4A29-881C-68FD1747E871Q92712080-7D249484-6420-4E23-8E9C-1CF2F63FF9C4Q93082727-A9A60216-EE57-4E0E-98CA-5083A819DB86
P50
description
investigador
@es
researcher
@en
name
Alan J Wigg
@en
type
label
Alan J Wigg
@en
prefLabel
Alan J Wigg
@en
P31
P496
0000-0001-8054-5745